
Will Biotech Buck The Historical Trend This March? (And Where Will Biotech Go After 2021?)
Historically, January and February tend to be very strong months for biotech, while March tends to be very weak. But, with COVID-19 continuing to bear…
Historically, January and February tend to be very strong months for biotech, while March tends to be very weak. But, with COVID-19 continuing to bear…
As the economic recovery continues, Goldman Sachs is advising investors to “balance the appeal of promising businesses with the risk that [interest] rates rise further…
When it comes to the first requirement to be a successful trend trader, the author of today’s article advises “You need to follow the ‘smart…
“These are three top stocks for investors with plenty of risk tolerance to consider for aggressive growth portfolios,” says the author of today’s article of…
What’s to love about trading options? Quite a bit! From reducing risk, to providing the flexibility to react to market volatility, to achieving consistent returns…
When it comes to insider buying, the author of today’s article notes that “Conventional wisdom says that insiders and 10% owners really only buy shares…
A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –…
With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in…
If stronger-than-expected fourth-quarter earnings, the prospect of massive government stimulus, and accelerating vaccine distribution has you feeling bullish, a perfect bet right now may be…
“The allure of penny stocks lies in their potential to deliver massive gains in a short period of time. But in exchange for that opportunity,…